Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems to File for IPO on Australian Stock Exchange

NEW YORK, June 25 (GenomeWeb News) - Proteome Systems has begun the process of filing an IPO with the Australian Stock Exchange, according to Keith Williams, the company's CEO.

Williams told ProteoMonitor this week that the company had to take a significant cut to its original planned listing price in order to go public. The company now plans to file with an approximately AU$160 million ($110 million) listing, compared with the AU$300 million ($206 million) that it had hoped for. Consequently, the company now aims to raise AU$35 million rather than an anticipated AU$45 million in the IPO. Patersons Securities is managing the stock float.

Williams expressed confidence in the stock's ability to succeed in the public market at the listed price. "I am pretty comfortable in terms of comparables, because many of the listed biotechs are at an early stage, [and] we have a real solid business in terms of 140 employees," Williams told ProteoMonitor. "So in comparable terms I think it was fairly easy to get to the price we got."

Still, Williams said an erratic growth pattern of the company's revenues was to blame for what he admitted has been a frustrating experience with investors. (For a complete version of this story see the June 25 issue of ProteoMonitor.)

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.